Viewing Study NCT01590459


Ignite Creation Date: 2025-12-24 @ 2:46 PM
Ignite Modification Date: 2025-12-26 @ 4:44 PM
Study NCT ID: NCT01590459
Status: COMPLETED
Last Update Posted: 2015-11-20
First Post: 2012-04-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking Methotrexate
Sponsor: Vertex Pharmaceuticals Incorporated
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module